ID: ALA4757277

Max Phase: Preclinical

Molecular Formula: C37H38N2O8

Molecular Weight: 638.72

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3c(cc4c(c3Oc3cc5c(cc3OC)CCN(OC)[C@@H]5C2)OCO4)CCN1OC

Standard InChI:  InChI=1S/C37H38N2O8/c1-40-30-10-7-23-16-28-27-20-33(31(41-2)18-24(27)11-13-38(28)42-3)47-37-35-25(19-34-36(37)45-21-44-34)12-14-39(43-4)29(35)15-22-5-8-26(9-6-22)46-32(30)17-23/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1

Standard InChI Key:  NEZCMOHYIOQPBK-WDYNHAJCSA-N

Associated Targets(Human)

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human coronavirus OC43 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.72Molecular Weight (Monoisotopic): 638.2628AlogP: 6.74#Rotatable Bonds: 4
Polar Surface Area: 80.32Molecular Species: NEUTRALHBA: 10HBD: 0
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 1.25CX LogP: 5.64CX LogD: 5.64
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.24Np Likeness Score: 1.56

References

1. Choudhry N,Zhao X,Xu D,Zanin M,Chen W,Yang Z,Chen J.  (2020)  Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).,  63  (22.0): [PMID:32845145] [10.1021/acs.jmedchem.0c00626]

Source